FluoGuide
YEAR END REPORT 2022
First North børs er den suverænt bedste børs for investorer
SEB initiates commissioned research on FluoGuide - IPO.se
Maximizing surgical outcomes Making cancer fluorescent - FluoGuide A/S
Pipeline - FluoGuide A/S
FluoGuide A/S - Stock and Shares News | IPO HUB
Fluoguides bestyrelsesformand trækker sig af personlige årsager
Fluoguide ser lovende resultater fra studie — MedWatch
FluoGuide A/S is awarded Best IPO in 2019 by the independent IPO Guide
FluoGuide
Spotlight Archives - Nyemission
Important information in English about the transfer to Nasdaq First North - FluoGuide A/S
Mød børsaktuelle FluoGuide - YouTube
106/19 – FluoGuide A/S will be listed on Spotlight Stock Market on May 7, 2019
FluoGuide søger notering på Spotlight | Et nyt dansk medico-selskab gør klar til børsnotering. Morten Albrechtsen, der er CEO i FluoGuide, fortæller her om selskabets første produkt, FG001, der... | By Nordnet
Morten Albrechtsen on LinkedIn: FluoGuide announces approval for listing on Nasdaq First North Growth…
BioSpace Global Roundup, May 21 | BioSpace
TRADING WITH SHARES LISTED ON SPOTLIGHT
Fluoguide flytter børs efter stigning på over 2000 pct.: "Det er starten på transformationen af selskabet" — MedWatch
FluoGuide ser lovende resultater fra studie
FluoGuide on Twitter: "FluoGuide plans to change listing venue from Spotlight to Nasdaq First North Sweden and publishes Company Description https://t.co/0ctU7Pzhpd" / Twitter
Spotlight and Fluoguide talks about IPOs and being a listed company - MVA
VEDTÆGTER/ARTICLES OF ASSOCIATION For FluoGuide A/S (“Selskabet” / the “Company”) CVR-nr./Central Business Register (
SEB initiates commissioned research on FluoGuide - IPO.se
